抗菌素抗藥性監測市場規模、佔有率和成長分析（按組件、技術、最終用戶和地區）- 產業預測（2025-2032）

預計 2023 年全球抗生素抗藥性監測市場價值將達到 59 億美元，並從 2024 年的 62.3 億美元成長到 2032 年的 96.3 億美元，預測期內（2025-2032 年）的複合年成長率為 5.6%。

抗生素抗藥性的蔓延已成為全球面臨的重大健康挑戰，促使各國政府、衛生組織和國際機構日益關注健全的監測系統。抗藥性感染疾病的增加導致對快速資料收集、病原體追蹤和抗藥性模式評估的需求激增，凸顯了對先進的抗生素抗藥性監測能力的需求，這些能力有助於快速檢測並做出明智的臨床決策。人們對公共衛生防範和感染控制的日益關注正推動市場擴張。同時，監管舉措和全球行動框架正在推動監測能力的提升。各國正在投資實驗室基礎設施和整合數據系統，以實現即時報告，從而提高調查效率。醫療保健提供者正在利用這些系統加強感染控制，並強調抗生素管理，以減少醫院相關感染，最終支持市場加速成長。

目錄

介紹

• 分析目的
• 市場覆蓋
• 定義

分析方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況與展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特分析

關鍵市場考量因素

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究

全球抗菌素抗藥性監測市場規模及各組成部分的複合年成長率（2025-2032）

• 市場概覽
• 軟體
• 硬體
• 服務

全球抗菌素抗藥性監測市場規模及複合年成長率（按技術分類）（2025-2032 年）

• 市場概覽
• 表現型方法
• 基因分型方法
• 生物資訊解決方案

全球抗菌素抗藥性監測市場規模及最終用戶複合年成長率（2025-2032）

• 市場概覽
• 醫院和診所
• 診斷實驗室
• 製藥和生物技術公司
• 學術研究機構
• 公共衛生機構

全球抗菌素抗藥性監測市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益同比對比（2022-2024 年）

主要企業簡介

• 生物梅里埃公司（法國）
• 賽默飛世爾科技公司（美國）
• BD（美國）
• 羅氏診斷（瑞士）
• OpGen公司（美國）
• Luminex公司（美國）
• Accelerate Diagnostics Inc.（美國）
• 默克集團（德國）
• 丹納赫公司（美國）
• 布魯克公司（美國）
• QuantuMDxGroup Limited（英國）
• ArcBio LLC（美國）
• Bugworks Research Inc.（印度）

結論和建議

Global Antimicrobial Resistance Surveillance Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.23 billion in 2024 to USD 9.63 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The escalating prevalence of antimicrobial resistance poses significant global health challenges, prompting heightened attention from governments, health organizations, and international bodies toward robust surveillance systems. The necessity for swift data collection, pathogen tracking, and resistance pattern assessment is surging in response to increasing drug-resistant infections, emphasizing the demand for advanced antimicrobial resistance surveillance capabilities that facilitate quick detection and informed clinical choices. This intensified focus on public health readiness and infection management is catalyzing market expansion. Concurrently, regulatory initiatives and global action frameworks are pressuring enhancements in surveillance capabilities. Nations are investing in laboratory infrastructure and integrated data systems for real-time reporting, thereby bolstering surveying efficiency. Healthcare providers leverage these systems to enhance infection control, emphasizing antimicrobial stewardship and reducing healthcare-associated infections, ultimately supporting accelerated market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Surveillance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Surveillance Market Segments Analysis

Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Surveillance Market

The growing prevalence of drug-resistant infections is now a significant public health concern, prompting urgent attention from health authorities worldwide. As resistance rates escalate, there is a pressing need for advanced surveillance systems that can monitor resistance patterns in real time, enabling timely interventions. Both national and local governments recognize the critical importance of enhancing antimicrobial resistance surveillance to effectively manage outbreaks, mitigate treatment failures, and inform public health policies. This collective effort to address the escalating issue of antimicrobial resistance has notably driven the expansion of the global antimicrobial resistance surveillance market, reflecting a commitment to safeguarding public health.

Restraints in the Global Antimicrobial Resistance Surveillance Market

The development of an effective antimicrobial resistance surveillance system faces considerable challenges, primarily due to the substantial financial investment needed for laboratory infrastructure, data integration technologies, and skilled workforce training. These constraints are especially pronounced in lower-income nations, where resources are often limited. Furthermore, the considerable expenses involved in analyzing surveillance data through genomic methods hinder the market's expansion and accessibility on a global scale. This combination of financial and operational hurdles poses significant obstacles that can impede the establishment and functionality of comprehensive surveillance systems crucial for combating antimicrobial resistance worldwide.

Market Trends of the Global Antimicrobial Resistance Surveillance Market

The global antimicrobial resistance surveillance market is witnessing a notable trend characterized by the integration of artificial intelligence with genomic surveillance techniques. This fusion enhances the effectiveness of monitoring efforts by utilizing AI-based platforms in conjunction with whole-genome sequencing and advanced bioinformatics tools. Such innovation enables the precise identification of resistance genes, timely outbreak alerts, and refined predictive modeling. Consequently, healthcare systems are empowered to bolster their surveillance capabilities, thereby improving response strategies and mitigating the spread of antimicrobial resistance. This shift towards technological advancements signifies a proactive approach to tackling one of the most pressing challenges in global health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Antimicrobial Resistance Surveillance Market Size by Component & CAGR (2025-2032)

• Market Overview
• Software
• Hardware
• Services

Global Antimicrobial Resistance Surveillance Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods
• Bioinformatics Solutions

Global Antimicrobial Resistance Surveillance Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Public Health Agencies

Global Antimicrobial Resistance Surveillance Market Size & CAGR (2025-2032)

• North America (Component, Technology, End User)
  • US
  • Canada
• Europe (Component, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcBio LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bugworks Research Inc. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations